Silicone Breast Implants by Gorczyca, David P.
UNIT A21.2Silicone Breast Implants
Magnetic resonance imaging is a powerful noninvasive means by which to study the
integrity of silicone breast implants. Silicone has a unique MR resonance frequency and
long T1 and T2 relaxation times that allow for several MR sequences to provide excellent
diagnostic images. The most commonly used sequences include T2-weighted and STIR
(short tau inversion recovery) imaging. The T2-weighted and STIR sequences are com-
monly used in conjunction with water suppression. The following are sequences that can
be used to investigate normal and ruptured silicone breast implants.
BASIC
PROTOCOL
IMAGING OF SILICONE BREAST IMPLANTS
An understanding of the MR characteristics of silicone will be helpful to understand why
certain MR sequences are used to differentiate silicone from surrounding breast paren-
chyma. As previously stated, silicone has a unique MR resonance frequency and long T1
and T2 relaxation times that allow for several MR sequences to provide diagnostic images.
The MR characteristics of silicone will be more thoroughly discussed in the Critical
Parameters section.
MR imaging of silicone breast implants is perfomed with a dedicated bilateral breast coil
using a 1.5 T superconducting magnet to help separate the MR signals from silicone, fat,
and water. To image patients with silicone breast implants, 4 MR sequences are used,
which require ∼30 min to complete the examination. Low field strength magnets can be
utilized to image the silicone breast implants, however, the signal separation between
silicone, fat, and water is poor on certain MR sequences.
Table A21.2.1 lists the necessary hardware to perform the procedure. The available
gradient strength will vary from scanner to scanner. The echo times will depend on the
MR system used. A dedicated bilateral breast coil is optimal for scanning, however, a
shoulder coil, round coil, or flex coil can be used on one breast at a time in the supine
position.
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no counterindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also,
be sure to find out if the patient has any health conditions that may require the
presence of special emergency equipment during the scanning procedure, or neces-
sitate any other precautions.
Generally, standard screening forms are used for all patients scanned in a magnetic
resonance system. The presence of any ferromagnetic metals may be a health hazard to the
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Table A21.2.1 Equipment Parameters Necessary for Imaging of Silicone Breast
Implants
Coil type Dedicated bilateral breast coil (phased-array if
available)
Gradient coil strength Depends on MR scanner
Cardiac gating No




Use of contrast agent No
A21.2.1
Breast
patient when he or she is inside the magnet, and will also affect the imaging. If in doubt as
to the exact composition of the items, it is best to exclude patients with any metal implants;
see Shellock and Kanal (1996) for discussion of what implants may be safely scanned using
magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If this is a research protocol, the patient should sign any necessary forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results, the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. The patient should be told to remove all clothes from the waist up and change into a
gown with the opening in front.
No contrast agent will be used for this MR examination so intraveneous access is not
required.
7. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
8. Then ask the patient to lie prone on the dedicated bilateral breast coil. The gown
should be opened in the front so the breast can be accurately placed in the breast coil.
9. Several pillows should be placed under the patient’s head. Have the patient’s arms
placed parallel to their body. If needed, place a pillow or other support under the knees
to make the patient more comfortable.
10. Use the centering light and center the patient’s nipples in the coil.
If the MR technologist is male, a female employee should be present at all times during set
up.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
11. If the patient is unable to hold still, provide an appropriate sedative.
12. The following 4 sequences consist of the preferred protocol, (1) a transverse scout
sequence, (2) a sagittal T2-weighted sequence with water suppression, (3) a transverse
T2-weighted sequence, and (4) a transverse STIR sequence with water suppression.
A GE signa 1.5 T scanner was used for this protocol.




Sequence 1: Rapid transverse positioning pilot
13. To validate the patient’s position, run the system’s pilot (or scout) scan to ensure
correct location of the breast, using the imaging sequence given in Table A21.2.2 or
similar parameters.
Sequence 2: Sagittal T2-weighted fast spin echo with water suppression
14. Bring the sequence for the sagittal T2-weighted fast spin echo with water suppression
up onto the console. Set the imaging parameters as shown in Table A21.2.3.
Table A21.2.2 Primary Clinical Imaging Parameters for Scout Sequence 1
(Pilot Scan)
Patient position Prone
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nipple of
breast
Echo time (TE) As short as possible
Repeat time (TR) As short as possible
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 360 mm, 360 mm
Resolution (∆x, ∆y) 1.41 mm, 2.81 mm
Number of data points collected (Nx, Ny) 256, 128
Slice thickness (∆z) 10 mm
Number of slices 10
Slice gap 5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Scan time ∼30 sec
Table A21.2.3 Primary Clinical Imaging Parameters for Sequence 2
(T2-Weighted Fast Spin Echo With Water Suppression)
Patient position Prone
Scan type Fast spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Image silicone implants only
Echo time (TE) 190–220 msec
Echo train length (ETL) 8–16
Repeat time (TR) 3000–5000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 200 mm, 320 mm (depends on
patient)
Resolution (∆x, ∆y) 0.78 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 30–38 (depends on patient)
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Water suppression Yes
Scan time ∼4 min
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15. Use the pilot images to locate the breast.
The image slices for this sequence should only cover the silicone implants in order to obtain
thinner slices in less time. This sequence is not designed to evaluate the entire breast
parenchyma for breast tumors.
16. Run the scan.
Sequence 3: Transverse T2 weighted fast spin echo
17. Bring the sequence for the sagittal T2-weighted fast spin echo up onto the console.
Set the imaging parameters as shown in Table A21.2.4.
18. Use the pilot images to locate the breast.
The image slices for this sequence should only cover the silicone implants in order to obtain
thinner slices in less time. This sequence is not designed to evaluate the entire breast
parenchyma for breast tumors.
19. Run the scan.
Sequence 4: Transverse inversion recovery fast spin echo sequence with water
suppression
20. Bring the sequence for the transverse T2-weighted fast spin echo up onto the console.
Set the imaging parameters as shown in Table A21.2.5.
21. Use the pilot images to locate the breast.
The image slices for this sequence should only cover the silicone implants in order to obtain
thinner slices in less time. This sequence is not designed to evaluate the entire breast
parenchyma for breast tumors.
This sequence provides more robust signal separation between silicone, fat, and water. The
fat and water signal will be suppressed making the silicone signal relatively high (silicone
Table A21.2.4 Primary Clinical Imaging Parameters for Sequence 3
(T2-Weighted Fast Spin Echo)
Patient position Prone
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Image silicone implants only
Echo time (TE) 190–220 msec
Echo train length (ETL) 8–16
Repeat time (TR) 3000–5000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 320 mm, 320 mm (depends on
patient)
Resolution (∆x, ∆y) 1.25 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 30–38 (depends on patient)
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Water suppression No
Scan time ∼4 min




only sequence). This is a good sequence if one is looking for free silicone in the breast
parenchyma. This sequence can only be performed consistently on a 1.5 T machine.
22. Run the scan.
Process and view the data
23. To better view the silicone implant images, adjust window level settings to see the
interior characteristics of the implants.
These MR sequences are optimized to evaluate silicone implants, not breast parenchyma
abnormalities. Therefore, the window level settings should be set to optimize the visuali-
zation of the silicone breast implants even at the expense of visualizing contrast in the breast
parenchyma. For the transverse breast images, have the technologist flip the images 180°
prior to printing in order to have the images in radiologic anatomic position.
COMMENTARY
Background Information
History of breast augmentation
During the last century, many different
methods have been tried to augment or recon-
struct the breast. Unfortunately, the majority of
approaches were disappointing with many as-
sociated complications. The methods used to
augment or reconstruct the breast can be placed
into one of three categories, autogenous tissue
transplantation, injectable materials, and im-
plantable prostheses.
Autogenous tissue transplantation
One of the first surgical uses of autogenous
tissue to correct a breast defect was performed
by Czerny in 1895. He removed a lipoma from
a patient’s thigh to fill out a breast defect. In the
mid 1920’s, free fat grafts were used for breast
augmentation; however, with time, liquefaction
or absorption of the free fat graft diminished
the cosmetic results. Abdominal fat flaps were
first described in the mid 1950’s and are still
used today, many with excellent cosmetic re-
Table A21.2.5 Primary Clinical Imaging Parameters for Sequence 4 (Inversion
Recovery Fast Spin Echo Sequence)
Patient position Prone
Scan type Inversion recovery fast spin echo 
Imaging plane (orientation) Transverse
Central slice or volume center Image silicone implants only
Echo time (TE) 190–220 msec
Echo train length (ETL) 8–16
Repeat time (TR) 3000–5000 msec
Inversion time (TI) 150 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 320 mm, 320 mm (depends on
patient)
Resolution (∆x, ∆y) 1.25 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 30–38 (depends on patient)
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Water suppression Yes
Scan time ∼5 min
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sults (Letterman and Schurter, 1989; Steinbach
et al., 1993).
Injectable materials
During the last century, many different ma-
terials have been injected into the breast in
attempts to augment the breast. One of the first
materials injected was paraffin. Several other
materials were also injected into the breast, but
most, if not all of the materials injected even-
tually resulted in a poor cosmetic outcome
secondary to complications. Complications in-
cluded granulomatous reactions, inflammatory
reactions, necrosis, pulmonary embolism, and
death. Direct silicone injections started in the
1950’s, again most with eventual complications
similar to those identified with paraffin injec-
tions (Letterman and Schurter, 1989; Steinbach
et al., 1993).
Implantable prostheses
In the 1950’s, synthetic sponge prostheses,
composed of polyvinyl alcohol or Ivalon, were
implanted in the breast. Initial reports were
promising, however, scar tissue quickly made
these prostheses hard and caused them to
shrink. Other synthetic materials were used
such as etheron, polyether polyurethane,
polypropylene, and even polytef (Teflon), all
resulting in complications or poor cosmetic
results. A new approach with promising cos-
metic results and less complications was re-
ported by Cronin and Gerow in 1963 when they
described their use of a silicone gel prosthesis
(Cronin and Gerow, 1964).
Several hundred different variations of sili-
cone gel prostheses have been made commer-
cially available over the past 40 years. Breast
implants have been placed in 1 to 2 million
women for augmentation mammoplasty or re-
construction after mastectomies. Despite the
initial enthusiasm, complications related to the
silicone-gel implants were reported. These
complications include rupture and leakage, fi-
brous or calcific contracture, localized pain,
pareshtesias, and possibly even generalized
autoimmune disorders. In 1992, the U.S. Food
and Drug Administration (FDA) held hearings
about potential complications resulting from
the use of silicone gel implants. As a result, the
FDA announced it would allow the use of
silicone gel implants only under special condi-
tions (Kessler, 1992).
Because of concerns about the potential dan-
gers of rupture and leakage of silicone-gel im-
plants, radiologists are often requested to evalu-
ate the integrity of breast prostheses. Mammog-
raphy, sonography, and MR imaging have been
used to evaluate the integrity of breast implants
(Ahn et al., 1993; Gorczyca et al., 1992; De-
Bruhl et al., 1993; Destouet et al., 1992; Eklund
et al., 1988; Harris et al., 1993; Sinha et al.,
1993). When compared with other imaging
techniques, MR imaging appears to be the most
accurate method for evaluating the integrity of
breast implants (Gorczyca et al., 1994a,b;
Mund et al., 1993; Gorczyca and Brenner,
1997).
Critical Parameters
An understanding of the MR characteristics
of silicone will be helpful to understand the
different MR sequences that can be used to
differentiate silicone from surrounding breast
parenchyma. The chemical composition of
most medical grade silicones is dimethyl
polysiloxane with varying degrees of polym-
erization (Fig. A21.2.1; Habal, 1984). The MR
signal is derived from the protons of the methyl
groups. The implant shell (envelope) is also
composed of silicone but differs from the gel
because of the many additional cross linkages
between the methyl groups that result in an
elastic solid. Although the implant shell is
composed of silicone, only minimal MR signal
is produced from the silicone shell because of
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Figure A21.2.1 Chemical composition of silicone (dimethyl polysiloxane).




The selection of MR pulse sequences used
to image breast implants is determined by the
relative Larmor precessional frequencies, as
well as the T1 and T2 properties of the tissues
(fat, muscle, and silicone). The relative reso-
nance frequency of silicone is ∼100 Hz lower
than fat and 320 Hz lower than water at 1.5 T
(Fig. A21.2.2). Since the resonance frequency
of silicone is close to fat, when chemical sup-
pression techniques (fat or water suppression)
are used, the MR signal from silicone behaves
similar to fat. As a result, the silicone signal is
high when water suppression is used (Table
A21.2.6) and the silicone signal is low when fat
suppression is used.
The relative relaxation times of silicone, fat,
and water can also be used to obtain MR images
that selectively emphasize the signal from sili-
cone. The relaxation times of fat are shorter
than those of silicone; therefore, one can use
the relaxation time properties of silicone and
fat to suppress the fat while maintaining a
strong signal from silicone. The use of inver-
sion recovery with a short TI (STIR) will sup-
press the signal from fat while maintaining
signal from silicone. To obtain a more selective
silicone image, a water suppression pulse can
be used in conjunction with an STIR sequence
to produce a silicone selective sequence.
Troubleshooting
Failure of water suppression
Occasionally, auto prescan will fail when a
water suppression sequence is being per-
formed. To correct this, go into manual prescan
(one should see a wave form similar to Fig.
A21.2.2—occasionally the fat and silicone
peak will merge into one flat peak), adjust to
the fat peak, save the frequency, and scan. One
helpful suggestion to individuals just starting
to image silicone implants is to place a small
bag of saline and a small silicone implant in the
breast coil when scanning the patient. The sa-
line and silicone bag act as controls so that the
radiologist can easily see on the images how
the saline and silicone are behaving on the MR
sequence being used.
Motion artifact
Do not confuse motion, cardiac, or respira-
tory artifacts with the collapsed silicone im-
plant shell. Most artifacts will extend beyond
the confines of the breast implants.
Window level
It is extremely important to adjust the win-
dow level setting to clearly see inside the sili-
cone breast implants. By adjusting the window




Figure A21.2.2 Relative resonance frequency differences between water, fat, and silicone at 1.5
T. The resonance frequency of silicone is ∼320 Hz lower than that of water and 100 Hz lower than
that of fat.
Table A.21.2.6 Relative Signal Intensities of Silicone, Fat, and Water
MR Sequence Silicone Fat Water
Fast spin echo (FSE) T2-weighted (TR ≅ 5000
msec, TE ≅ 200 msec)
High Medium Very high
FSE with water suppression High Medium Low
Inversion recovery FSE (IRFSE) (TR ≅ 5000
msec, TE ≅ 200 msec, TI = 150 msec)
High Low Very high
IRFSE with water suppression High Low Low




Figure A21.2.3 A 34-year-old woman with normal subpectoral single-lumen silicone implants. (A)
Sagittal T2-weighted FSE with water suppression. Pectoralis major muscle = curved arrow. (B)
Transverse T2-weighted FSE demonstrates a normal signal-lumen subpectoral silicone implant with
normal radial folds (arrows) of the silicone shell extending to the periphery of the implant. These
folds are not indicative of rupture or leak.





Figure A21.2.4 A 48-year-old woman with normal subglandular double-lumen silicone implants.
(A) Sagittal T2-weighted FSE with water suppression. Pectoralis major muscle = curved arrow. (B)
Transverse T2-weighted FSE. The very high signal intensity (arrows) surrounding the lower signal
silicone on the transverse image (B) represents the saline-filled outer lumen. The saline outer lumen
is of low-signal-intensity (straight arrows) on the sagittal T2-weighted FSE with water suppression
(A).




Figure A21.2.5 Intracapsular rupture. (A) Unlike an intact implant (left), in early intracapsular
ruptures (center), silicone gel surrounds implant shell, but is contained by the fibrous capsule. Later,
the collapsed implant shell floats within the silicone gel (linguine sign, right). Light gray line = fibrous
capsule, black line = implant shell. (B) Patient presented with pain in both breasts. Sagittal
T2-weighted image shows multiple curvilinear low-signal-intensity lines within the left implant known
as the linguine sign (arrows). Intracapsular rupture of the left implant was found at surgery.





Figure A21.2.6 Extracapsular rupture. (A) Intact implant has uninterrupted shell and fibrous
capsule (left). Disruption of shell and fibrous capsule (center) will allow silicone to extravasate into
surrounding breast tissue (right). Light gray line = fibrous capsule, black line = implant shell. (B)
Patient presented with right breast pain. The sagittal T2-weighted image demonstrates extracapsu-
lar silicone (straight white arrow) and collapse of the silicone shell (straight black arrow), M =
pectoralis muscle.
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collapsed implant shell or normal radial folds.
These MR sequences are optimized to evaluate
silicone implants, not breast parenchymal ab-
normalities, therefore, concentrate on window-
ing on the silicone implants, not the breast
tissue.
Saline implants
Radiologists new to MR imaging of silicone
implants can become easily confused by saline
implants if they are imaged by MRI. If a breast
implant is completely dark when a water sup-
pression sequence is performed, the implant is
not a silicone implant—it is a saline implant. If
the radiologist is not sure, a bag of saline can
be placed in the coil and compared with the
breast implant. Furthermore, saline implants do
not have to be imaged by MR imaging because
when saline implants rupture, the saline is ab-
sorbed by the body. Ruptured saline implants
can be easily detected by mammography.
Anticipated Results
Appearance of normal implants
Several hundred different types of breast
implants were commercially available over the
past 40 years (Middleton and McNamara,
2000). Most silicone implants are composed of
an outer silastic elastomer shell (envelope),
filled with viscous silicone gel. The implants
are usually oval and have a smooth or textured
surface. After surgical placement, a thin fibrous
capsule (scar tissue) normally forms around the
prosthesis. MR imaging often shows radial
folds, normal infoldings of the silastic elas-
tomer shell (Fig. A21.2.3). These folds may
appear prominent, but should not be confused
with implant rupture or leak. Radial folds, even
when prominent, extend to the periphery of the
implant and the folds are relatively few in
number.
Although hundreds of different types of sili-
cone implants have been produced, single-lu-
men (Fig. A21.2.3) and double-lumen silicone
implants (Fig. A21.2.4) are the most commonly
encountered. A single-lumen silicone implant
has an outer silastic shell containing the viscous
silicone gel. A double-lumen silicone implant
typically has an inner lumen that contains the
thick viscous silicone gel surrounded by a
smaller outer lumen that contains saline. Breast
implants may be surgically placed in a subglan-
dular location, that is, anterior to the pectoralis
major muscle, or subpectoral, posterior to the
pectoralis major muscle (Fig. A21.2.3 and Fig.
A21.2.4).
A variety of other types of implantable pros-
theses are occasionally encountered, including
expander implants (reverse double lumens—
saline in the inner lumen, silicone in the outer
lumen), multicompartmental implants, foam
implants, and single lumen silicone implants
with saline directly injected into the silicone at
the time of surgery. Occasionally, two or even
more implants are placed in one breast, a con-
figuration commonly known as stacked im-
plants. Some implants have a coating of poly-
urethane covering the surface of the silicone
envelope. These implants typically have a mod-
erate to large amount of reactive fluid surround-
ing the implant. The many different implant-
able prosthesis can be easily differentiated from
direct silicone injections into the breast. Saline
implants, where the lumen is filled with saline
have become more popular since the FDA lim-
ited the use of silicone gel implants in 1992.
Appearance of ruptured breast implants
Implant ruptures can be divided into two
major categories, intracapsular and extracapsu-
lar rupture.
Intracapsular implant rupture, the most
common type of rupture, is defined as rupture
of the implant shell (elastomer envelope) with
silicone leakage that does not macroscopically
extend beyond the fibrous capsule that com-
monly forms around silicone implants (Gor-
czyca et al., 1992). The most reliable MR cri-
terion for intracapsular rupture is the presence
Figure A21.2.7 (at right) Focal rupture without complete collapse (uncollapsed implant rupture)
or extensive gel bleed of implant shell. (A) Normal infolding of implant shell causes radial folds (left).
Gel bleed is microscopic silicone leakage through an intact implant shell (center). Silicone may
enter a radial fold, resulting in an inverted teardrop sign (right). A focal tear in the implant shell
without complete collapse of the implant shell (uncollapsed implant rupture) can have an identical
appearance. Light gray line = fibrous capsule, black line = implant shell. (B) Focal rupture of implant
shell without complete collapse of implant shell (uncollapsed implant rutpure). Sagittal T2-weighted
FSE image shows inverted teardrop signs (straight arrow), indicating silicone within a radial fold
and outside of the implant lumen itself. At surgery, a small tear within the implant shell was found.
The inverted teardrop sign is not specific, this sign has been seen with both focal ruptures and
extensive gel bleeds with intact implant shells. 





Figure A21.2.7 (See legend on facing page.)
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of multiple curvilinear low-signal-intensity
lines seen within the high-signal-intensity sili-
cone gel, the so-called linguine sign (Fig.
A21.2.5). These curvilinear lines represent the
collapsed implant shell floating within the sili-
cone gel. Rarely, intracapsular rupture will
show multiple hyperintense foci on T2-
weighted images or multiple hypointense foci
on water-suppression images within the im-
plant lumen. When less than six foci of water
droplets are identified within a silicone implant
without other evidence of rupture, one must be
careful not to definitely diagnose a ruptured
implant. The authors have three cases that all
showed several small water droplets within the
implants (no other MR findings were noted to
suggest rupture) and all proved to be intact at
the time of surgery.
Extracapsular silicone implant ruptures are
defined as ruptures of both the implant shell
and the fibrous capsule with macroscopic sili-
cone leakage that extends beyond the fibrous
capsule into surrounding tissues. Focal areas of
high signal intensity, representing free silicone,
can be identified on MR images (Fig. A21.2.6).
In addition to free silicone in the surrounding
breast parenchyma, the linguine sign is often
present with extracapsular ruptures. The mul-
tiplanar capabilities of MR imaging allow pre-
cise localization of free silicone.
Unlike ruptures, gel bleed is microscopic
silicone leakage through an intact implant shell
(Brody, 1977). Most if not all implants will
eventually have gel bleed, however, the major-
ity of gel bleeds cannot be detected by MR
imaging. Only when gel bleed is extensive can
silicone gel be detected outside the silicone
shell. A focal or early intracapsular rupture can
have a similar appearance to a large gel bleed
and it can be difficult if not impossible to
differentiate these two entities on MR images
(Fig. A21.2.7).
In the authors’ experience, other signs, such
as focal or diffuse irregularity of the contour of
the implant or reactive fluid surrounding the
implant, are not reliable signs of silicone im-
plant rupture.
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